As part of the agreement, PDS Biotech received $25 million at the close and can receive an additional $10 million if needed. The loan will be paid back over 48 months, according to an Aug. 24 PDS Biotech news release provided to Becker’s.
Proceeds from the loan agreement will be used to support the clinical development of drug candidates.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.